TRACON PHARMACEUTICALS INC (TCON)
US89237H3084 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.56M | 17.43M | 24.07M | 32.13M | 16.41M | |||
| Marketable Securities | N/A | N/A | 0.00 | 4.00M | 0.00 | |||
| Other Current Assets | 526.00K | 800.00K | 860.00K | 780.00K | 850.00K | |||
| Total Current Assets | 9.09M | 18.23M | 24.94M | 36.91M | 17.26M | |||
| Non-Current Assets | ||||||||
| PPE Net | 942.00K | 1.17M | 1.38M | 520.00K | 860.00K | |||
| Investments And Advances | 0.00 | 0.00 | N/A | N/A | N/A | |||
| Other Non-Current Assets | 73.00K | 70.00K | 250.00K | N/A | N/A | |||
| Total Non-Current Assets | 1.01M | 1.24M | 1.62M | 530.00K | 860.00K | |||
| TOTAL ASSETS | 10.11M | 19.47M | 26.56M | 37.44M | 18.12M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 9.81M | 1.39M | 2.72M | 2.60M | |||
| Accrued Expenses | 7.64M | 8.64M | 7.34M | 6.10M | 1.71M | |||
| Accounts Payable | 2.54M | 3.92M | 4.94M | 1.73M | 7.52M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 10.18M | 22.37M | 13.68M | 10.54M | 11.83M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 1.39M | 2.74M | |||
| Other Non-Current Liabilities | 732.00K | 4.25M | 1.17M | 430.00K | 850.00K | |||
| Total Non-Current Liabilities | 732.00K | 4.25M | 1.16M | 1.83M | 3.59M | |||
| TOTAL LIABILITIES | 10.91M | 26.62M | 14.84M | 12.37M | 15.42M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -240.50M | -236.91M | -207.78M | -179.11M | -162.33M | |||
| Additional Paid In Capital | 239.65M | 229.74M | 219.47M | 204.17M | 165.03M | |||
| Common Shares | 44.00K | 20.00K | 20.00K | 20.00K | 0.00 | |||
| Shares Outstanding | 2.21M | 23.13M | 19.45M | 15.48M | 4.05M | |||
| Tangible Book Value per Share | -0.37 | -0.31 | 0.60 | 1.62 | 0.67 | |||
| Total Shareholders' Equity | -809.00K | -7.15M | 11.71M | 25.07M | 2.70M | |||
| TOTAL LIABILITIES AND EQUITY | 10.11M | 19.47M | 26.56M | 37.44M | 18.12M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.06 | 1.01 | |||
| Current Ratio | 0.89 | 0.81 | 1.82 | 3.50 | 1.46 | |||
| Return On Assets (ROA) | -35.51% | -149.67% | -107.94% | -44.82% | -125.11% | |||
| Return On Equity (ROE) | N/A | N/A | -244.83% | -66.93% | -839.63% | |||
All data in USD